Endometrial carcinoma risk factors, with special reference to the use of oestrogens
- PMID: 6996404
Endometrial carcinoma risk factors, with special reference to the use of oestrogens
Abstract
A review of literature, mainly the results of studies conducted in America, shows obesity, diabetes mellitus, hypertension, infertility/nulliparity, late menopause, high endogenous oestrogen production, and the use of oestrogens to be the main factors associated with the development of endometrial carcinoma. Whilst most of these factors undoubtedly apply irrespective of country, doubt in Finland about the use of oestrogens being a risk factor was one of the reasons prompting the study reported here. This study, which was conducted in Turku, Finland, involved 318 endometrial carcinoma patients, 282 of whom could be paired with controls matched for age, height and weight, and social class. The data show the use of oestrogens per se not to be a risk factor. The fact that there appears to be a risk in America, where most of the oestrogenic preparations used are based on conjugated equine oestrogens, but not in Finland, where the preference is for preparations based on oestriol and oestradiol and where conjugated oestrogen preparations are relatively rarely used, supports the hypothesis that the risk depends on the type of oestrogen used.
Similar articles
-
Risk factors in endometrial carcinoma with special reference to the use of estrogens.Acta Obstet Gynecol Scand Suppl. 1979;86:1-119. Acta Obstet Gynecol Scand Suppl. 1979. PMID: 377899 Review. No abstract available.
-
The risk of endometrial carcinoma from oestrogen therapy of the menopause.Acta Endocrinol Suppl (Copenh). 1980;233:29-35. Acta Endocrinol Suppl (Copenh). 1980. PMID: 6773285 Review.
-
[Estrogen therapy and carcinoma of the endometrium (author's transl)].Geburtshilfe Frauenheilkd. 1978 Sep;38(9):735-43. Geburtshilfe Frauenheilkd. 1978. PMID: 210085 German.
-
Oestrogens and endometrial hyperplasia.Br J Hosp Med. 1980 May;23(5):506, 508-9, 511-3. Br J Hosp Med. 1980. PMID: 6992895 Review.
-
Estrogens and endometrial cancer.J Med. 1981;12(2-3):81-8. J Med. 1981. PMID: 6944429
Cited by
-
Hormone replacement therapy and breast cancer, endometrial cancer and cardiovascular disease: risks and benefits.Br J Gen Pract. 1992 Mar;42(356):120-5. Br J Gen Pract. 1992. PMID: 1493029 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical